<- Go Home
Neuro Bioscience Inc.
Neuro Bioscience, Inc., a development-stage biotechnology company, through its subsidiary, focuses on the discovery, development, and commercialization of drugs or procedures to treat diseases and disorders of the human central nervous system. The company is based in New York, New York.
Market Cap
$710.00
Volume
15.00
Cash and Equivalents
N/A
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$0.01
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
0.00
Price / Earnings
-0.00
Price / Tangible Book Value
-0.00
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$1.6M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
N/A
Debt
N/A
Equity
$16.5M
Revenue
N/A
Unlevered FCF
N/A
Sector
Biotechnology
Category
N/A